Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New hernia surgery may cut pain by 30%

NCT ID NCT05528107

Symptom relief Sponsor: City Clinical Hospital No.1 named after N.I. Pirogov Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compared two minimally invasive surgeries for incisional hernia (a bulge at a previous surgical scar). 72 adults with a midline hernia were randomly assigned to get either the standard IPOM Plus or the newer eTEP repair. The main goal was to see if eTEP caused less pain the day after surgery. Researchers also checked pain at 7 and 30 days after the operation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

72 people

The number who actually took part.

Started

Feb 2023

Finished

Jul 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * midline incisional hernia * defect width 2-6 cm * ASA I-II class * Elective hernia repair * Considered eligible for minimally invasive ventral hernia repair * Able to give informed consent * Able to tolerate general anesthesia Exclusion Criteria: * primary ventral herna * lateral hernia with/without midline * defect width more than 6 cm * refuse to give informed consent * prior mesh placement in the retrorectus space

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Incisional hernia of midline of abdomen are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Pain

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Incisional hernia of midline of abdomen

Contacts and locations

Locations

  • Clinical City Hospital #1 named after N.I. Pirogov

    Moscow, Russia

More trials for these conditions

Other studies related to the condition(s) this trial covers.